SANDRA REINERS: Open Payments
NPI 1356503759 · DUSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 21 payments from 10 companies in 2025. Trend: 2023 $185 · 2024 $404 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $165 |
| GENZYME CORPORATION | 2 | $77 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $55 |
| Organon LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: DUPIXENT, FANAPT, CAPLYTA, NUCALA, VRAYLAR, MOUNJARO, ZEPBOUND, XHANCE.
Industry payments across LA — which companies pay providers there.
